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Abstract An 80-year-old man was admitted to our hos-
pital because of the rupture of the liver. Laboratory data
showed iron-deﬁciency anemia, although there was no liver
dysfunction. A computed tomography scan showed large
liver tumor with intraperitoneal hemorrhage, and since a
serum level of a-fetoprotein (AFP) was extremely high, we
initially suspected a rupture of hepatocellular carcinoma
(HCC). Transarterial embolization was performed to stop
bleeding from the tumor, followed by an endoscopic
examination that revealed advanced gastric cancer. Histo-
logical analysis revealed that both the gastric and the
hepatic tumors were moderately to poorly differentiated
adenocarcinoma, as well as that both tumors were immu-
nohistochemically positive for AFP. Finally, we diagnosed
AFP-producing gastric cancer associated with liver
metastasis. Rupture of metastatic liver cancer is rare, and
accordingly, distinction from HCC is important, particu-
larly for the cases of AFP-producing gastric cancer.
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Introduction
a-Fetoprotein (AFP) is a well-known tumor marker for
hepatocellular carcinoma (HCC). A type of gastric cancer
has been identiﬁed to produce AFP [1]. AFP-producing
gastric cancers have characteristics of an unusual clinical
course, with events not seen in the cases of common gastric
cancer such as rapid growth and easy metastasis to the liver
[2]. We herein report a case of AFP-producing gastric
cancer that resembled HCC owing to the complication of
liver rupture.
Case report
An 80-year-old man was admitted to our hospital because
of sudden and severe abdominal pain. He had no history of
liver disease. Physical examination revealed tenderness at
the right costal region.
The laboratory data showed no liver dysfunction.
Markers for hepatitis viruses except for hepatitis B core
antigen (anti-HBc) were all negative. As for tumor mark-
ers, serum levels of carbohydrate antigen 19-9 were
slightly elevated. On the other hand, serum AFP level was
extremely high at 21,090 ng/ml. AFP analysis showed a
broadband pattern of AFP, different from the typical pat-
tern of HCC. The level of serum des-c-carboxy-
prothrombin was normal (Table 1).
A computed tomography scan showed large tumor in
the right lobe of the liver and ﬂuid collection within the
tumors (Fig. 1). The thickened gastric wall was also
seen. Under the ultrasonographic guidance, rupture of a
liver tumor was diagnosed on the basis of the collected
bloody ﬂuid. Emergency angiography revealed a huge
hypervascular tumor in segment 6 of the liver, and
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DOI 10.1007/s12072-008-9072-3transarterial embolization (TAE) was immediately per-
formed to control the bleeding from the tumor (Fig. 2).
Endoscopic examination performed on the following
day revealed Borrmann III type advanced cancer at the
cardiac region of the stomach (Fig. 3).
Gastric biopsy demonstrated moderately to poorly dif-
ferentiated adenocarcinoma. In the histological section,
hepatoid differentiation of cancer cells was not seen. In
order to distinguish a metastatic lesion of gastric cancer of
the liver from gastric cancer complicated with HCC, we
also performed a biopsy of the liver tumor. The liver tissue
showed moderately differentiated adenocarcinoma,
resembling the gastric lesion, and both the gastric and the
liver lesions were positive for AFP immunohistochemically
(Fig. 4). We also conﬁrmed the production of AFP in the
cancer cells by reverse transcription polymerase chain
reaction. Finally, we diagnosed AFP-producing gastric
cancer together with liver metastasis.
TAE was able to completely control the tumor bleeding.
However, the patient and his family refused further treat-
ment, such as chemotherapy, and the patient was then
transferred to another hospital for supportive care.
Table 1 Laboratory investigations
WBC 10,000 /ul HBsAg (-)
RBC 337 9 10
4/ll Anti-HBc (+)
Hb 9.6 g/dl HBV-DNA \2.6 LEG/ml
Plt 25.1 9 10
4/ll Anti-HCV (-)
HCV-RNA (-)
T-Protein 6.0 g/dl
Albumin 2.8 g/dl AFP 21,090 ng/ml
(normal\10)
T-Bilirubin 1.4 mg/dl DCP 26 mAU/ml
(normal\40)
AST 43 IU/l CEA 3.4 ng/ml
(normal\5)
ALT 20 IU/l CA19-9 50 U/ml
(normal\37)
LDH 197 IU/l
ALP 278 IU/l
c-GTP 99 IU/l
Fig. 1 A computed tomography scan showing large tumor in the
right lobe of the liver and ﬂuid collection within the tumor
Fig. 2 Emergency angiography revealing a huge hypervascular tumor
in segment 6 of the liver (arrow heads). Transarterial embolization was
immediately performed to control the bleeding from the tumor
Fig. 3 Endoscopic examination, performed on the following day,
showing Borrmann III type advanced cancer at the cardiac region of
the stomach
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a-Fetoprotein-producing gastric cancer is relatively rare,
and a metastatic liver lesion from such cancer is often
difﬁcult to discern from HCC through a differential diag-
nosis. The present case was in fact a case of spontaneous
rupture of AFP-producing gastric cancer of the liver. It
should be noted, however, that we had initially suspected
HCC rather than metastatic liver cancer up until the results
of endoscopic examination.
Spontaneous liver rupture is sometimes seen in the cases
of HCC; however, it is rare in other liver tumors. Rupture
of metastatic liver cancer is also uncommon [3]. It may
result from insufﬁcient blood supply to the tumor. How-
ever, details of the mechanism for spontaneous liver
rupture have remained obscure.
A report of liver rupture in AFP-producing gastric
cancer similar to the present case has been previously
reported [4]. Angiography demonstrated that the ruptured
liver tumor was a hypervascular tumor as well. This ﬁnding
resembles with that seen in HCC. AFP-producing gastric
cancer is known to show rapid growth and invasion to
small vessels [5]. In addition, hypervascularity may be
associated with spontaneous tumor rupture.
Rupture of the tumor is one of the life-threatening
complications. Mortality of patients with ruptured HCC in
the acute phase remains high [6]. Some reports have rec-
ommended selective hepatic artery ligation or emergency
hepatectomy as the treatments of choice in patients with
limited tumors [7]. Recently, TAE has been chosen in
many patients with ruptured HCC. Development of TAE
technique has improved the prognosis of patients with
ruptured HCC [8].
Particularly in this case where the patient suffered from
AFP-producing gastric cancer complicated by liver rupture
and positive ﬁndings for serum HBc antibody, the dis-
tinction from HCC was critically important. Positivity for
HBc antibody sometimes suggests occult HBV infection
associated with other risk factors of HCC in several liver
diseases, including cryptogenic cirrhosis and chronic hep-
atitis C [9].
The patient in the present case did not wish to receive
any further treatment because there are no established
chemotherapy regimens for AFP-producing gastric cancer.
The prognosis of AFP-producing gastric cancer has been
reported to be very poor. Furthermore, most of these cases
show resistance to anticancer drugs. Recently, S-1, a novel
oral derivative of 5-ﬂuorouracil, was developed, and its
effectiveness against advanced gastric cancer has been
reported [10]. Its effect against some cases of AFP-pro-
ducing gastric cancer has also been reported; however,
further investigations are called for with regard to the
treatment of AFP-producing gastric cancer.
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Fig. 4 (a) Gastric tumor
showing moderately
differentiated adenocarcinoma.
(b) The ﬁndings of the liver
tumor resembled that of the
gastric lesion. Both (c) the
gastric and (d) the liver lesions
were positive for AFP
immunohistochemically
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